Medicines A–Z
T
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Tolterodine tablets | ||
 |
Tolvaptan (Jinarc®) | Tolvaptan (Jinarc) for treating autosomal dominant polycystic kidney disease |
|
 |
Tolvaptan (Samsca®) | Consultant advice only. Tolvaptan (Samsca) for the treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
|
|
Topiramate tablets | Prophylaxis of migraine. Specialist recommendation. |
|
|
Topotecan capsules | For hospital use only |
|
|
Toripamate tablets | ||
 |
Trabectedin injection | ||
|
Tramadol | ||
|
Tramadol capsules | Second line after morphine and codeine. Soluble tablets - high relative cost - patients with swallowing difficulties. |
|
|
Tramadol soluble tablets | Second line after morphine and codeine. Soluble tablets - high relative cost - patients with swallowing difficulties. |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
